Detection of Minimal Residual Disease in B Lymphoblastic Leukemia Using viSNE

By Joseph A. DiGiuseppe, Michelle D. Tadmor, Dana Pe'er. 2015

46 citations recorded by the source corpus.

Minimal residual disease (MRD) following treatment is a robust prognostic marker in B lymphoblastic leukemia. However, the detection of MRD by flow cytometric immunophenotyping is technically challenging, and an automated method to detect MRD is therefore desirable. viSNE, a recently developed computational tool based on the t‐Distributed Stochastic Neighbor Embedding (t‐SNE) algorithm, has been shown to be capable of detecting synthetic “MRD‐like” populations of leukemic cells created in vitro, but whether viSNE can facilitate the immunophenotypic detection of MRD in clinical samples has not been evaluated.

Subfields: Hematology, Molecular Biology, Public Health, Environmental and Occupational Health

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

  1. Eirini Arvaniti
  2. Manfred Claassen

In Molecular Biology

  1. J. Snyder-Cappione
  2. Josef Spidlen
  3. Eirini Arvaniti
  4. Anna C. Belkina
  5. Manfred Claassen
  6. Blaz Zupan
  7. Pavlin Gregor Policar
  8. Martin Stražar

In Public Health, Environmental and Occupational Health

  1. Eirini Arvaniti
  2. Manfred Claassen

Citations in the corpus